glucose, (beta-d)-isomer has been researched along with tamoxifen in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, R; Hirayama, A; Kasahara, T; Kusui, K; Suzuki, K; Watanabe, H | 1 |
| Chen, J; Corey, P; Saggar, JK; Thompson, LU | 1 |
| Cheong, JH; Choi, JS; Jung, HA; Kim, DH; Kim, JM; Ko, KH; Lee, S; Park, SJ; Ryu, JH | 1 |
| Araujo, JMD; Camargo, EA; Felix, FB; Grespan, R; Silva, LAS; Souza, EV | 1 |
| Abo-Saif, AA; El-Sayed El-Daly, M; Moustafa Ahmed, Y; Shehata Messiha, BA | 1 |
| Jiang, M; Li, N; Pi, J; Ren, X; Sun, L; Tan, L; Wang, M; Yu, X | 1 |
| Li, X; Luo, G; Shen, M; Shi, J; Tang, L; Wang, Q; Wang, X; Wang, Y | 1 |
| Hermawan, A; Nugroho, EP; Wibowo, MA | 1 |
8 other study(ies) available for glucose, (beta-d)-isomer and tamoxifen
| Article | Year |
|---|---|
Bisphenol A significantly enhances the neutrophilic differentiation of promyelocytic HL-60 cells.
Topics: Benzhydryl Compounds; CD18 Antigens; Cell Differentiation; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; HL-60 Cells; Humans; Neutrophils; Phenols; Phosphoproteins; Proto-Oncogene Proteins; Superoxides; Tamoxifen; Trans-Activators; Zymosan | 2003 |
Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Butylene Glycols; Cell Line, Tumor; Cell Proliferation; Female; Flax; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Lignans; Linseed Oil; Mice; Mice, Nude; Phytotherapy; Random Allocation; Receptors, Estrogen; Receptors, Growth Factor; RNA, Messenger; Seeds; Signal Transduction; Tamoxifen; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
The effects of daidzin and its aglycon, daidzein, on the scopolamine-induced memory impairment in male mice.
Topics: Animals; Avoidance Learning; Cholinergic Antagonists; Estrogen Antagonists; Glucosides; Isoflavones; Learning Disabilities; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Phytoestrogens; Receptors, Estrogen; Scopolamine; Swimming; Tamoxifen | 2010 |
Agonistic activity of tamoxifen, a selective estrogen-receptor modulator (SERM), on arthritic ovariectomized mice.
Topics: Animals; Arthritis, Experimental; Cell Migration Assays, Leukocyte; Cell Movement; Disease Models, Animal; Estrogen Antagonists; Estrous Cycle; Female; Mice; Neutrophils; Organ Size; Ovariectomy; Random Allocation; Reproducibility of Results; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Treatment Outcome; Uterus; Zymosan | 2017 |
Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro.
Topics: AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Aorta; Arthritis, Rheumatoid; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Endothelium, Vascular; Female; Glucosides; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Kinases; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred WF; Receptors, Purinergic P2Y12; Selective Estrogen Receptor Modulators; Sodium-Glucose Transporter 2 Inhibitors; Tamoxifen; Ticagrelor; Vascular Cell Adhesion Molecule-1; Vasodilation | 2019 |
Preparation and Characterization of PLGA-PEG-PLGA Nanoparticles Containing Salidroside and Tamoxifen for Breast Cancer Therapy.
Topics: Animals; Breast Neoplasms; Drug Delivery Systems; Female; Glucosides; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Phenols; Polyethylene Glycols; Polyglactin 910; Rats; Rats, Sprague-Dawley; Tamoxifen | 2020 |
Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis.
Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Breast Neoplasms; Cell Proliferation; Cell Survival; Cyclin D1; Down-Regulation; Drug Screening Assays, Antitumor; Female; Forkhead Box Protein O1; Glucosides; Humans; MicroRNAs; Monoterpenes; Tamoxifen; Tumor Cells, Cultured | 2021 |
Genomic Understanding Reveals the Important Role of FGFR2 as Paeoniflorin Target for Circumventing Breast Cancer Resistance to Tamoxifen.
Topics: Antineoplastic Agents; Breast Neoplasms; Computational Biology; Databases, Genetic; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genomics; Glucosides; Humans; Kaplan-Meier Estimate; Monoterpenes; Protein Interaction Maps; Receptor, Fibroblast Growth Factor, Type 2; Signal Transduction; Tamoxifen | 2021 |